Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Platelets, also known as thrombocytes, are small, colorless cell fragments in the blood that play a crucial role in hemostasis—the process of stopping bleeding. They are produced from megakaryocytes in the bone marrow and circulate in the bloodstream for 7–10 days. When a blood vessel is injured, platelets adhere to the site of damage (adhesion), become activated (changing shape and releasing chemical signals), and aggregate to form a platelet plug. This primary hemostatic response is reinforced by fibrin through activation of the coagulation cascade (secondary hemostasis). Platelet transfusions are used therapeutically or prophylactically to treat or prevent bleeding due to low platelet counts (thrombocytopenia) or dysfunctional platelets. In addition to their role in clotting, platelets contain cytokines and growth factors that promote wound healing and tissue regeneration[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on platelets.